Difficulty: Medium
Average Score: 78%
Testbank
A patient has been exposed to a nerve agent in a biochemical terrorist attack. This type of agent bonds with acetylcholinesterase, so that acetylcholine is not inactivated. What is the pathologic effect of this type of agent?
Correct answer
A
Rationale
Hyperstimulation of the nerve endings occurs due to the accumulation of acetylcholine when acetylcholinesterase is inhibited by the nerve agent.
This leads to excessive stimulation of the postsynaptic receptors, resulting in continuous activation of the muscles and glands innervated by those nerves. The sustained presence of acetylcholine causes symptoms such as muscle twitching, spasms, and potentially paralysis due to overactivity.
B: Temporary deactivation of the nerve endings suggests a reversible process, which does not apply here as the nerve agent causes prolonged stimulation rather than deactivation.
C: Binding of the nerve endings implies a physical attachment without functional consequences; however, the agent's binding leads to a pathological state of overstimulation, not mere binding.
D: Destruction of the nerve endings indicates irreversible damage, which is not the immediate effect of acetylcholinesterase inhibition; rather, it causes functional disruption without destroying the nerve structure.
This leads to excessive stimulation of the postsynaptic receptors, resulting in continuous activation of the muscles and glands innervated by those nerves. The sustained presence of acetylcholine causes symptoms such as muscle twitching, spasms, and potentially paralysis due to overactivity.
B: Temporary deactivation of the nerve endings suggests a reversible process, which does not apply here as the nerve agent causes prolonged stimulation rather than deactivation.
C: Binding of the nerve endings implies a physical attachment without functional consequences; however, the agent's binding leads to a pathological state of overstimulation, not mere binding.
D: Destruction of the nerve endings indicates irreversible damage, which is not the immediate effect of acetylcholinesterase inhibition; rather, it causes functional disruption without destroying the nerve structure.